Top 5 Healthcare Stocks for the Future

3. IVERIC bio, Inc. (NASDAQ:ISEE)

Dr. Bardon’s healthcare-focused hedge fund was one of numerous funds to take a stake in IVERIC bio, Inc. (NASDAQ:ISEE) over the last year, doing so in the fourth quarter of 2019. 26 hedge funds were Iveric shareholders on September 30, up from just five a year earlier. Burrage Capital owned just under 1.50 million ISEE shares on September 30.

Hedge funds have regained interest in the company, formerly called Opthotech Corporation, after its transition to gene therapies and the successful trial of its C5 inhibitor Zimura, which provided a 28% relative benefit compared to placebo in the treatment of geographic atrophy. The condition affects about 1 million people in the U.S and 5 million worldwide and has no FDA-approved treatment. Iveric Bio made a $50 million stock offering in June which should help carry it through Zimura’s march to commercialization.